New option for ICU patients who Won't settle with standard sedatives
NCT ID NCT07457593
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This program offers inhaled isoflurane, given through a special device, to sedate adult ICU patients on breathing machines who are difficult to sedate with usual IV medicines. It aims to help patients who remain agitated or at risk of harming themselves despite standard treatments. The goal is to improve comfort and safety for these critically ill individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEDATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentle oxygen boost make lung biopsies safer and faster?
- A Mother's voice as medicine? trial tests comforting effect on ventilated children
- A single score may spot breathing trouble before it's too late in sedated children
- New sedation cocktail aims to protect elderly patients during routine scopes
- Which sedation drug is safer for mom and baby during C-Section?
- Heart risk under the knife: new study tracks anesthesia dangers in rare cardiac condition